TGFB1 and Hepatic fibrosis: Another ARB, losartan, significantly ameliorated the progression of hepatic fibrosis induced by carbon tetrachloride (CCl4) in rats along with significant reductions in gene expression levels of AT1R and TGF-β1 [50].